|
... Masimo sarà una società operativa indipendente all'interno del segmento Diagnostics di Danaher, insieme a Radiometer, Leica Biosystems, Cepheid e Beckman Coulter Diagnostics. Si prevede che Masimo ...
Finanza Repubblica
-
17-2-2026
|
|
|
|
The intuitive motion user interface simplifies diagnostics and manual operations through a user - friendly graphical interface. For immersive visuals, the simulator uses high - definition projectors ...
01Net
-
16-2-2026
|
|
|
|
Together, these insights enable biopharma, diagnostics, and investors to benchmark performance, identify inflection points in adoption, and prioritize commercial and evidence - generation strategies ...
01Net
-
16-2-2026
|
|
|
|
... skincare, fashion, jewelry, and watch brands and retailers by supplying them with omnichannel shopping experiences through AR product try - ons and AI - powered skin diagnostics. With cutting - edge ...
01Net
-
13-2-2026
|
|
|
|
Che aggiunge: 'Diagnostics continua a risentire degli effetti di una fase di transizione nel mercato cinese'. com - san. Gli ultimi video Radiocor 13 - 02 - 26 12:17:17 (0307)SAN 5 NNNN
Borsa Italiana
-
13-2-2026
|
|
|
|
... GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics ...
01Net
-
13-2-2026
|
|
|
|
Chart - aware Diagnostics is in alpha with select partners and will roll out broadly in the coming months. Early pilots of Chart - Aware Coding are underway with select health system partners. This ...
01Net
-
12-2-2026
|
|
|
|
Intelligent Diagnostics is reshaping what s possible in ATM uptime and service quality. By turning data into actionable guidance at scale, we re giving our customers a more reliable, resilient ATM ...
01Net
-
12-2-2026
|
|
|
|
The ADDF has a longstanding track record of advancing transformative Alzheimer s diagnostics, including early support for technologies such as the first amyloid PET scan and the first blood - based ...
01Net
-
10-2-2026
|
|
|
|
L'esame di breve periodo di Quest Diagnostics classifica un rafforzamento della fase rialzista con immediata resistenza vista a 210 USD e primo supporto individuato a 194,9. Tecnicamente ci si ...
La Stampa Economia
-
10-2-2026
|
|
|
